Radiological Image of the Tyrosine Kinase Inhibitors Response of Metastatic Renal Cell Carcinoma

Laura Cerón, Juan Carlos Aparicio, Victoria Garriga, Sara Cros, Ana Narbona and Jorge Hernández
Additional contact information
Jorge Hernández: Radiology Department, Hospital General de Granollers, Spain

Cancer Therapy & Oncology International Journal, 2018, vol. 10, issue 3, 35-40

Abstract: Renal cell carcinoma (RCC) represents 2-3% of adult malignant tumors and constitutes 90% of the malignant tumors that affect the kidney. RCC metastatic disease (m-RCC) occurs in a significant percentage and is usually associated with an overall poor prognosis. This tumor is hypervascular and that is why tyrosine kinase inhibitors (TKI), that target the intracellular kinase domain of the vascular endothelial growth factor receptor, have become established as the most successful drug in this disease. These drugs interfere in the angiogenesis of the RCC, thus modifying the radiological image by CT with contrast, making them necessary to study the evolution of the radiological aspect of the findings. Because of mechanism of action of TKI is complex and its effect is different according to the organ in which they act, a heterogeneous radiological response of the metastatic lesions can be expected. Knowledge of this different behavior depending on the organ is mandatory to correctly evaluate the response to treatment.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555786.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555786.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:10:y:2018:i:3:p:35-40

DOI: 10.19080/CTOIJ.2018.10.555786

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().